The most important word beside Mochi’s low medication quote is “plus.” A membership is required and the medicine price varies by the prescribed dose, so the displayed starting figure is not an all-in program price.
- Reviewed product
- Compounded semaglutide injection
- Public price boundary
- Starting medicine quote $60; membership additional
- Prescription
- Required; eligibility determined clinically
- Research date
- October 8, 2026
Identify the exact product
Mochi’s current page describes a compounded weekly subcutaneous semaglutide preparation. It explicitly says that compounded medications are not FDA-approved and that medication cost is excluded from membership. This review records the public quote without assuming the supply period or the total checkout amount.[source]
What the evidence applies to
Compounded semaglutide has not received FDA approval as a finished medicine. FDA recommends compounding only when an approved drug cannot meet the patient’s medical needs. Clinical results for branded semaglutide should not be presented as verified outcomes of this particular prescription.[source]
Understand the complete cost
The page showed a $60 starting quote plus membership, with dose-dependent pricing. Obtain the membership amount, medicine supply duration and actual charge at the proposed prescription before calculating a monthly total. Older flat-price descriptions should not replace the current page.[source]
Care, refills and practical details
The described process includes a questionnaire, video visit, pharmacy coordination and ongoing care. Ask how medical questions and pharmacy-label questions are routed. Do not infer that unlimited visits guarantees immediate availability or a particular response time.[source]
Safety questions come before the price
FDA has identified concerns including dosing errors, inappropriate dose escalation and unapproved salt forms in the compounded GLP-1 market. Obtain treatment through a licensed prescriber and pharmacy, and ask why an approved drug cannot meet the clinical need. These medicines can have serious adverse effects; a low price is not a safety assessment.[source]
Compare a genuinely similar option
CoreAge Rx advertises a different price presentation, while Ro and Hers offer branded-product pathways. Compare care and drug status first, then normalize the billing period. The smallest standalone medicine number may still produce a different total after membership.
Read the full provider review and the total-cost guide before treating any headline as the complete treatment budget.
Your questions, answered
Is the displayed price my guaranteed total?
No. It is the public price boundary recorded on the review date. The prescribed product, dose, membership, billing period and eligibility can change the amount you pay.
Did you buy or test this treatment?
No. This is a source-based product and access review. We did not obtain a prescription, purchase medication or independently test treatment results.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- Mochi: compounded semaglutideStarting medication quote; dose-dependent; membership extra
- FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags
- NIDDK: prescription medicines for overweight and obesityEligibility, long-term care, treatment context and insurance questions